8-K: NorthView Acquisition Corp. Faces Nasdaq Delisting Threat Due to Late Filing

Sentiment:

Delisting Notice


NorthView Acquisition Corp. received a delisting notice from Nasdaq for failing to file its quarterly report, putting its listing status at risk.

Delay expectedThe company failed to file its Quarterly Report on Form 10-Q for the period ended September 30, 2024, on time, leading to the delisting notice.The company had previously failed to file its Quarterly Reports on Form 10-Q for the periods ended March 31, 2024 and June 30, 2024 on time.
Worse than expectedThe company received a delisting notice from Nasdaq, indicating a failure to meet listing requirements.

Summary

  • NorthView Acquisition Corp. received a notice from Nasdaq due to the company's failure to file its Form 10-Q for the period ended September 30, 2024.
  • This non-compliance with Nasdaq Listing Rule 5250(c)(1) could lead to the delisting of the company's securities.
  • The company has 60 days, until February 4, 2025, to submit a plan to regain compliance.
  • If Nasdaq accepts the plan, the company may be granted up to 180 days, until May 19, 2025, to regain compliance.
  • The company expects to file its Form 10-Q within the 60-day period, potentially avoiding the need for a formal compliance plan.
  • The company's securities may be delisted if it fails to meet the 36-month deadline for completing a business combination, which is December 20, 2024.
  • The company has applied to list its securities on the OTCQB market, but there is no guarantee of approval.
  • A delisting could significantly impact the company's ability to raise capital and reduce liquidity for its stock.
  • The company is still pursuing its merger with Profusa, Inc., and intends to list the combined entity on Nasdaq after the merger.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the delisting notice, the company's non-compliance with Nasdaq rules, and the risk of liquidation if the merger is not completed. While the company is working to resolve the issues, the situation is precarious.

Positives

  • The company expects to file its Form 10-Q within the 60-day period, potentially avoiding the need for a formal compliance plan.
  • The company is still pursuing its merger with Profusa, Inc., and intends to list the combined entity on Nasdaq after the merger.
  • The company has applied to list its securities on the OTCQB market as a backup plan.

Negatives

  • The company received a delisting notice from Nasdaq for failing to file its Form 10-Q for the period ended September 30, 2024.
  • The company is not in compliance with Nasdaq Listing Rule 5250(c)(1).
  • The company faces a December 20, 2024 deadline to complete a business combination or face immediate delisting.
  • A delisting could significantly impact the company's ability to raise capital and reduce liquidity for its stock.
  • There is no guarantee that the company's application to list on the OTCQB market will be approved.

Risks

  • The company faces potential delisting from Nasdaq if it does not regain compliance with listing rules.
  • Failure to complete a business combination by December 20, 2024, will result in immediate delisting.
  • Delisting could lead to reduced liquidity for the company's stock and difficulty in raising future capital.
  • There is no guarantee that the company's application to list on the OTCQB market will be approved.
  • If the Profusa Business Combination is not consummated, the company may be forced to liquidate.

Future Outlook

The company is working to file its Form 10-Q for the period ended September 30, 2024, within the 60-day period to avoid submitting a formal compliance plan. The company is also pursuing its merger with Profusa, Inc., and intends to list the combined entity on Nasdaq after the merger. However, the company faces a deadline to complete a business combination by December 20, 2024, or face immediate delisting.

Management Comments

  • The Company is working diligently to complete its Form 10-Q for the period ended September 30, 2024.
  • The Company expects to file its Form 10-Q within the 60-day period described above, which would eliminate the need for the Company to submit a formal plan to regain compliance.

Industry Context

This announcement highlights the challenges faced by special purpose acquisition companies (SPACs) in meeting regulatory deadlines and completing business combinations within the required timeframe. The risk of delisting is a significant concern for SPACs that fail to meet these requirements, potentially impacting investor confidence and the company's ability to operate effectively.

Comparison to Industry Standards

  • Many SPACs face similar challenges in meeting deadlines for financial reporting and business combinations.
  • The 36-month deadline for completing a business combination is a standard requirement for SPACs listed on Nasdaq.
  • Failure to meet these deadlines can lead to delisting, which is a common risk for SPACs that do not successfully complete a merger within the allotted time.
  • Other SPACs such as Digital World Acquisition Corp. (DWAC) have faced similar scrutiny and delays in their merger processes, highlighting the regulatory hurdles and time constraints in the SPAC market.

Stakeholder Impact

  • Shareholders face the risk of delisting, which could significantly reduce the value of their investment.
  • Employees may experience uncertainty due to the company's financial and listing challenges.
  • Customers and suppliers may be impacted by the company's potential delisting and merger plans.
  • Creditors may be concerned about the company's ability to meet its obligations if it is delisted or forced to liquidate.

Next Steps

  • The company must file its Form 10-Q for the period ended September 30, 2024, within 60 days.
  • The company may need to submit a plan to regain compliance with Nasdaq listing rules.
  • The company must complete a business combination by December 20, 2024, to avoid immediate delisting.
  • The company will continue to pursue its merger with Profusa, Inc.
  • The company will seek approval to list its securities on the OTCQB market.

Key Dates

DateDescription
June 3, 2024Company received a delinquency notification letter from Nasdaq for failing to file its Quarterly Report on Form 10-Q for the period ended March 31, 2024.
September 12, 2024Company received a letter from Nasdaq indicating non-compliance for failing to file its Quarterly Report on Form 10-Q for the period ended June 30, 2024.
October 9, 2024Company filed its Quarterly Report on Form 10-Q for the period ended March 31, 2024.
October 14, 2024Original deadline for filing the Quarterly Reports on Form 10-Q for the periods ended March 31, 2024 and June 30, 2024.
October 15, 2024Company received a letter from Nasdaq notifying partial compliance for filing the March 31, 2024 report and granting an extension.
November 15, 2024Company filed its Quarterly Report on Form 10-Q for the period ended June 30, 2024.
November 18, 2024Extended deadline for filing the Quarterly Report on Form 10-Q for the period ended June 30, 2024.
November 21, 2024Company received a letter from Nasdaq notifying partial compliance for filing the June 30, 2024 report but remained non-compliant due to the outstanding September 30, 2024 report.
December 6, 2024Company received a delinquency notification letter from Nasdaq for failing to file its Quarterly Report on Form 10-Q for the period ended September 30, 2024.
December 11, 2024Company issued a press release announcing the receipt of the delisting notice.
December 20, 2024Deadline for the company to complete a business combination or face immediate delisting.
February 4, 2025Deadline for the company to submit a plan to regain compliance with Nasdaq listing rules.
May 19, 2025Potential extended deadline for the company to regain compliance with Nasdaq listing rules if a plan is accepted.

Keywords

delisting, Nasdaq, Form 10-Q, compliance, business combination, merger, OTCQB, liquidity, capital raise, Profusa

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.